PepGen Inc.
NASDAQ: PEPG0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- James McArthur
- Employees
- 56
- Headquarters
- Boston, United States
- IPO year
- 2022
- Market cap
- $122.4M
- Website
- https://www.pepgen.com
Loading PEPG…
Loading profile data…Frequently asked questions about PEPG
What does PepGen Inc. (PEPG) do?
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1;...
Where does PEPG trade?
PepGen Inc. (PEPG) trades on the NASDAQ.
What sector is PEPG in?
PepGen Inc. (PEPG) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of PepGen Inc.?
James McArthur is the chief executive officer of PepGen Inc. (PEPG).
Where is PepGen Inc. headquartered?
PepGen Inc. is headquartered in United States.
Does PEPG pay a dividend?
PepGen Inc. (PEPG) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PEPG go public?
PepGen Inc. (PEPG) completed its initial public offering in 2022.